NFG
MRNA icon

Next Financial Group’s Moderna MRNA Stock Holding History

Next Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$1.62M Buy
6,383
+1,424
+29% +$416K 0.11% 212
2021
Q3 		$1.91M Sell
4,959
-2,459
-33% -$907K 0.15% 153
2021
Q2 		$1.74M Buy
7,418
+76
+1% +$13.6K 0.14% 166
2021
Q1 		$961K Sell
7,342
-67
-0.9% -$9.71K 0.09% 249
2020
Q4 		$774K Buy
7,409
+6,493
+709% +$657K 0.07% 269
2020
Q3 		$65K Buy
+916
New +$63.9K 0.01% 1015
2020
Q2 		– Sell
-281
Closed -$8K – 1390
2020
Q1 		$8K Buy
+281
New +$6.46K ﹤0.01% 1595

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Next Financial Group's MRNA Position: Q4 2021 in Review

Next Financial Group increased its Moderna (MRNA) stake by 29% in Q4 2021, buying an estimated $416K and bringing the position to 6,383 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #212.

Next Financial Group first reported a position in MRNA in Q1 2020 and has held it in 7 quarters since. The position peaked at $1.91M in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Next Financial Group held 6,383 shares of Moderna worth $1.62M as of Q4 2021.
  • Next Financial Group bought 1,424 Moderna shares in Q4 2021, an estimated $416K.
  • Moderna made up 0.11% of Next Financial Group's portfolio in Q4 2021, its #212 holding.
  • Next Financial Group first reported a position in Moderna in Q1 2020 and has held it in 7 quarters since.
  • Next Financial Group's Moderna position peaked at $1.91M in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.